Alkem Laboratories Ltd. benchmarking: Performance to industry peers

Financial

	Alkem Laboratories	Glenmark Pharma	Abbott India
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	188.0 .	13.0 .	n/a
Number of ANDA's Approved By USFDA	167.0 .	25.0 .	n/a
Number of ANDA's Filed in Europe	18.0	n/a	n/a
Number of ANDA's Approved in Europe	12.0	n/a	n/a
Number of ANDA's Filed in Australia	42.0	n/a	n/a
Number of ANDA's Approved by Australia	32.0	n/a	n/a
Domestic Sales Growth - YoY	9.5 %	13.3 %	6.0 %
R&D as a % of Total Sales	3.7 %	7.3 %	0.02 %
Financials
5 yr Average ROE	17.38 %	7.81 %	30.11 %
5yr average Equity Multiplier	1.39	1.78	1.43
5yr Average Asset Turnover Ratio	0.86	0.8	1.14
5yr Avg Net Profit Margin	14.54 %	2.85 %	18.53 %
Price to Book	4.93	6.64	11.97
P/E	27.74	59.76	36.83
5yr Avg Cash Conversion Cycle	-61.46 Days	-150.94 Days	-46.68 Days
Inventory Days	56.11 Days	32.28 Days	45.22 Days
Days Receivable	44.62 Days	32.34 Days	19.34 Days
Days Payable	122.42 Days	201.14 Days	109.21 Days
5yr Average Interest Coverage Ratio	24.48	4.25	97.37
5yr Avg ROCE	22.76 %	17.54 %	38.77 %
5yr Avg Operating Profit Margin	18.44 %	15.96 %	23.42 %
5 yr average Debt to Equity	0.18	0.38	0.0
5yr CAGR Net Profit	6.44 %	1.54 %	95.4 %
5yr Average Return on Assets	12.47 %	2.09 %	21.03 %
Shareholdings
Promoter Holding	51.2 %	46.65 %	74.99 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-5.96 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	5.38 %	11.37 %	0.8 %

Business

	Alkem Laboratories	Glenmark Pharma	Abbott India
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Hormones 0 Anti Diabetic 0 Central Nervous System 0 Respiratory 0 Vaccines 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Women`s health 0 Gastro Intestinal 0 Pain 0	Product Wise Break-Up Respiratory 0 Gastro Intestinal 0 Central Nervous System 0 Vaccines 0 Branded Generics 60.46 Pain 0 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Anti Diabetic 0 Anti-Infectives 0 Formulations 39.54 Metabolic 0 Pharmaceutical 0 Derma 0 cardiovascular system 0 Women`s health 0 Hormones 0	Product Wise Break-Up Respiratory 0 Gastro Intestinal 25.46 Central Nervous System (CNS) 12.65 Vaccines 0 Glenmark Pharma (Branded generics) 0 Pain 0 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Anti Diabetic 42.82 Anti-Infectives 0 Glenmark generics 0 Metabolic 0 Pharmaceutical 0 Derma 0 cardiovascular system 0 Women`s health 0 Hormones 11.59 Others 7.48
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti-Infective 33.8 Gastro Intestinal 21.2 Vitamins / Minerals / Nutrients 12.0 Pain Management 10.1 Anti - Diabetes 5.0 Gynecology 4.1 Central Nervous System (CNS) 3.7 Respiratory 3.0 Derma 2.4 Cardiac Science 2.3 Others 2.4	-	-
Location Wise Break-Up	Location Wise Break-Up India 66.79 USA 32.53 Rest of the World 0 Europe 0 Latin America 0 North America 0 Others 0.68	Location Wise Break-Up Latin America 0 India 33.49 USA 0 North America 25.03 Rest of the World 20.94 Europe 20.54	Location Wise Break-Up Latin America 0 India 98.81 USA 0 North America 0 Rest of the World 1.19 Europe 0
Asset Break-Up	Asset Break-Up India 70.19 USA 28.27 Rest of the World 0 Europe 0 Latin America 0 North America 0 Others 1.54	Asset Break-Up Latin America 0 India 49.4 USA 0 North America 42.56 Rest of the World 4.94 Europe 3.09 Others 0.01	-

Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

Financial

Business

SIGN UP FOR FREE